A fully integrated point-of-care test for ebola

Ended Project Grant Awarded Last action

Award ID
R01AI150888
Recipient
Awarding agency
Obligated
$5,591,779

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Funding
  • $4,874,352.85 Federal
  • $717,426.00 Non-federal
Place of performance
North Carolina, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$2,675 $0
Amendment $590,199 $0
Amendment $590,199 $0
Amendment $772,176 $0
Amendment $772,176 $0
Amendment $717,426 $0
Amendment $717,426 $717,426
Original award $717,426 $0

Subawards

Subrecipient Amount Awarded
University Of Texas Medical Branch At Galveston Specific Aims: This subcontract will support Aim 3. SA3 – In vitro validation of the D4 assay in biologically relevant matrixes and testing with… $74,759
Biostealth Inc. Biostealth will provide the chips required to complete this project and develop a transition from laser cut chips to higher volume manufacturing techniques,… $120,000

Quick answers

Who received award R01AI150888?

R01AI150888 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 23, 2020.

How much is award R01AI150888 worth?

$5,591,779 has been obligated on R01AI150888: $4,874,353 in federal funding and $717,426 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login